Skip to main content
Back
MOH logo

Molina Healthcare, Inc.

Data quality: 100%
MOH
NYSE Healthcare Medical - Healthcare Plans
$141.74
▲ $6.50 (4.81%)
Mkt Cap: 7.30B
Day Range
$132.88 $142.11
52-Week Range
$121.06 $359.97
Volume
1,497,320
50D / 200D Avg
$160.65 / $181.77
Prev Close
$135.24

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 15.5 0.3
P/B 1.8 2.9
ROE % 11.0 3.7
Net Margin % 1.0 3.8
Rev Growth 5Y % 13.1 10.0
D/E 1.0 0.2

Analyst Price Target

Hold
$175.64 +23.9%
Low: $124.00 High: $310.00
Forward P/E
26.8
Forward EPS
$5.04
EPS Growth (est.)
+0.0%
Est. Revenue
45 B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $25.38
$23.65 – $27.55
 53 B 2
FY2029 $19.10
$17.80 – $20.73
 50 B 2
FY2028 $12.34
$10.37 – $13.34
 49 B 4

Key Takeaways

Revenue grew 13.09% annually over 5 years — strong growth
Earnings declined -59.97% over the past year
ROE of 11.02% — decent returns on equity
Negative free cash flow of -636.00M
Capital efficient — spends only 0.22% of revenue on capex

Growth

Revenue Growth (5Y)
13.09%
Revenue (1Y)11.75%
Earnings (1Y)-59.97%
FCF Growth (3Y)N/A

Quality

Return on Equity
11.02%
ROIC7.30%
Net Margin1.04%
Op. Margin1.72%

Safety

Debt / Equity
0.97
Current Ratio1.69
Interest Coverage4.07

Valuation

P/E Ratio
15.47
P/B Ratio1.79
EV/EBITDA8.96
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.75% Revenue Growth (3Y) 15.47%
Earnings Growth (1Y) -59.97% Earnings Growth (3Y) -34.23%
Revenue Growth (5Y) 13.09% Earnings Growth (5Y) -8.01%
Profitability
Revenue (TTM) 45.43B Net Income (TTM) 472.00M
ROE 11.02% ROA 3.03%
Gross Margin 8.97% Operating Margin 1.72%
Net Margin 1.04% Free Cash Flow (TTM) -636.00M
ROIC 7.30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.97 Current Ratio 1.69
Interest Coverage 4.07 Dividend Yield 0.00%
Valuation
P/E Ratio 15.47 P/B Ratio 1.79
P/S Ratio 0.16 PEG Ratio -0.33
EV/EBITDA 8.96 Dividend Yield 0.00%
Market Cap 7.30B Enterprise Value 7.00B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 45.43B 40.65B 34.07B 31.97B 27.77B
Net Income 472.00M 1.18B 1.09B 792.00M 659.00M
EPS (Diluted) 8.92 20.42 18.78 13.54 11.25
Gross Profit 4.08B 4.74B 4.33B 3.93B 3.28B
Operating Income 781.00M 1.71B 1.57B 1.17B 1.02B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.56B 15.63B 14.89B 12.31B 12.21B
Total Liabilities 11.50B 11.13B 10.68B 9.35B 9.58B
Shareholders' Equity 4.07B 4.50B 4.22B 2.96B 2.63B
Total Debt 3.95B 3.12B 2.39B 2.39B 2.39B
Cash & Equivalents 4.25B 4.66B 4.85B 4.01B 4.44B
Current Assets 12.44B 12.77B 12.54B 10.08B 10.06B
Current Liabilities 7.37B 7.90B 8.17B 6.86B 7.05B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#382 of 618
28

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026